Cargando…
Optimal anti-amyloid-beta therapy for Alzheimer’s disease via a personalized mathematical model
With the recent approval by the FDA of the first disease-modifying drug for Alzheimer’s Disease (AD), personalized medicine will be increasingly important for appropriate management and counseling of patients with AD and those at risk. The growing availability of clinical biomarker data and data-dri...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477429/ https://www.ncbi.nlm.nih.gov/pubmed/36054214 http://dx.doi.org/10.1371/journal.pcbi.1010481 |